![John St. Clair Roberts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John St. Clair Roberts
Chief Tech/Sci/R&D Officer at Elastagen Pty Ltd.
Network origin in John St. Clair Roberts first degree
Entity | Entity type | Industry | |
---|---|---|---|
Elastagen Pty Ltd.
![]() Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia.
8
| Subsidiary | Medical Specialties | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John St. Clair Roberts via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard Business School | College/University | Undergraduate Degree Masters Business Admin | |
Brandon Capital Partners Pty Ltd.
![]() Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Private Equity Investor Private Equity Investor | |
AusBiotech Ltd.
![]() AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University College London | College/University | Doctorate Degree | |
Respirion Pharmaceuticals Pty Ltd.
![]() Respirion Pharmaceuticals Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Respirion Pharmaceuticals Pty Ltd. operates as a biotechnology firm. It focuses on development new treatments for respiratory diseases. The company was founded by Barry Clements in 2018 and is headquartered in Iluka, Australia. | Miscellaneous Commercial Services | Director/Board Member | |
MecRx Pty Ltd.
![]() MecRx Pty Ltd. Pharmaceuticals: MajorHealth Technology MecRx Pty Ltd. develops drugs for treatment of cancer. The company was founded by Ian Holmes, Jo Alcindor, Tom Peat and Janet Newman in 2013 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member | |
PharmaVentures Ltd.
![]() PharmaVentures Ltd. Investment ManagersFinance Pharma Ventures Ltd. provides advisory services on life sciences transactions. It offers mergers and acquisitions, licensing, strategy and valuation, and expert services. The firm's industry coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. The company is headquartered in Oxford, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Cancer Therapeutics CRC Pty Ltd.
![]() Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Biotechnology | Director/Board Member | |
Apax Partners LLP
![]() Apax Partners LLP Investment ManagersFinance Apax Partners LLP engages in providing investment services. It focuses on investing in firms across the global sectors such as technology and telecommunications, services, healthcare, and consumer. The company was founded by Ronald Mourad Cohen and Alan J. Patricof in 1969 and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member | |
Vaxxas Pty Ltd.
![]() Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | Medical Specialties | Director/Board Member | |
Imperial College London | College/University | Masters Business Admin | |
Australian Graduate School of Entrepreneurship | College/University | Graduate Degree | |
Tel-Aviv University
![]() Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree | |
Celleron Therapeutics Ltd.
![]() Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue. | Pharmaceuticals: Major | Director/Board Member | |
KAHR Medical Ltd.
![]() KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Gordon Research Conferences | Chairman | ||
CLEARVIEW WEALTH LIMITED | Investment Managers | Director/Board Member | |
ServiceRocket Inc.
![]() ServiceRocket Inc. Miscellaneous Commercial ServicesCommercial Services ServiceRocket, Inc. provides training, utilization and support services for software companies. Its products include Learndot, Trusted Advisor, and Atlassian add-ons. The firm also offers training, utilization, support and Atlassian services and training. The company was founded by Robert Castaneda in 2001 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Chairman | |
AMPLIA THERAPEUTICS LIMITED | Biotechnology | Director/Board Member | |
King's College London | College/University | Doctorate Degree | |
GBS Venture Partners Pty Ltd.
![]() GBS Venture Partners Pty Ltd. Investment ManagersFinance GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne. | Investment Managers | Founder | |
University of Melbourne
![]() University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Undergraduate Degree | |
HUMANIGEN, INC. | Biotechnology | Director/Board Member |
Statistics
International
Australia | 12 |
United Kingdom | 9 |
United States | 7 |
Israel | 3 |
France | 2 |
Sectoral
Health Technology | 12 |
Consumer Services | 8 |
Finance | 6 |
Commercial Services | 5 |
Miscellaneous | 2 |
Operational
Director/Board Member | 48 |
Chairman | 18 |
Corporate Officer/Principal | 8 |
Independent Dir/Board Member | 7 |
Undergraduate Degree | 5 |
Most connected contacts
Insiders | |
---|---|
Brigitte Smith | 28 |
Stephen Thompson | 18 |
Xavier Yon | 16 |
Andrew Sneddon | 14 |
Robert Daniels | 6 |
Sangwoon Lee | 4 |
Michal Graff Mitzmacher | 3 |
Anthony Weiss | 2 |
- Stock Market
- Insiders
- John St. Clair Roberts
- Company connections